Details of the Drug Reposition

General Information of This Drug (ID: DMRJFN9)

• Drug Name: Theophylline (DMRJFN9)
• Synonyms: Bronchoretard; Cetraphylline; Chronophyllin; Dimethylxanthine; Elixophylline; Liquophylline; Pseudotheophylline; Afonilum Retard; Bronchodid Duracap; Elixophyllin SR; Somophyllin CRT; Spophyllin retard; Telbans DrySyrup; Teofilina [Polish]; Theal tablets; Theobid Duracap; Theodur Dry Syrup; Uniphyllin continus; Elixophyllin (TN); Elixophyllin(e); Pulmo-Timelets; Somophyllin-CRT; Somophyllin-DF; Theo-Organidin; Theoclear-200; Theodur G (TN); Theolair (TN); Theophylline (JP15); Theophylline-SR; Quibron-t (TN); Theo-Dur-Sprinkle; Theophylline-[8-3H; Theoclear L.A.-130; 1,3 Dimethylxanthine; 1,3-Dimethylxanthine; 1H-purine-2,6-dione
• Therapeutic Class: Bronchodilator Agents
• Drug Type: Small molecular drug

Information on Drug Reposition of This Drug

5 Approved Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Pulmonary disease	DIS6060I	1B10-1F85	Approved	[1]
Non-small-cell lung cancer	DIS5Y6R9	2C25.Y	Approved	[1]
Bronchitis	DISBM6EQ	CA20	Approved	[1]
Pulmonary emphysema	DIS5M7HZ	CA21.Z	Approved	[1]
Severe asthma	DISAVQI3	CA23	Approved	[1]

1 Discontinued in Phase 3 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Chronic obstructive pulmonary disease	DISQCIRF	CA22	Discontinued in Phase 3	[2]

References

• [1] Theophylline FDA Label
• [2] Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors